These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17133498)

  • 1. The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected livers.
    Vilasco M; Larrea E; Vitour D; Dabo S; Breiman A; Regnault B; Riezu JI; Eid P; Prieto J; Meurs EF
    Hepatology; 2006 Dec; 44(6):1635-47. PubMed ID: 17133498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.
    Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF
    J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
    Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
    J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of interferon production by RIG-I and LGP2: a lesson in self-control.
    Vitour D; Meurs EF
    Sci STKE; 2007 May; 2007(384):pe20. PubMed ID: 17473309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functions.
    Kaukinen P; Sillanpää M; Nousiainen L; Melén K; Julkunen I
    J Med Virol; 2013 Jan; 85(1):71-82. PubMed ID: 23096996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection.
    Ito M; Masumi A; Mochida K; Kukihara H; Moriishi K; Matsuura Y; Yamaguchi K; Mizuochi T
    J Innate Immun; 2010; 2(6):607-17. PubMed ID: 20714117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
    Vazquez C; Tan CY; Horner SM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.
    Yu S; Chen J; Wu M; Chen H; Kato N; Yuan Z
    J Gen Virol; 2010 Aug; 91(Pt 8):2080-2090. PubMed ID: 20375222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Kinase MAP4K1 Inhibits Cytosolic RNA-Induced Antiviral Signaling by Promoting Proteasomal Degradation of TBK1/IKKε.
    He TS; Huang J; Chen T; Zhang Z; Cai K; Yu J; Xu LG
    Microbiol Spectr; 2021 Dec; 9(3):e0145821. PubMed ID: 34908452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
    Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation.
    Schröder M; Baran M; Bowie AG
    EMBO J; 2008 Aug; 27(15):2147-57. PubMed ID: 18636090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interferon inducing pathways and the hepatitis C virus.
    Meurs EF; Breiman A
    World J Gastroenterol; 2007 May; 13(17):2446-54. PubMed ID: 17552028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity.
    Nitta S; Sakamoto N; Nakagawa M; Kakinuma S; Mishima K; Kusano-Kitazume A; Kiyohashi K; Murakawa M; Nishimura-Sakurai Y; Azuma S; Tasaka-Fujita M; Asahina Y; Yoneyama M; Fujita T; Watanabe M
    Hepatology; 2013 Jan; 57(1):46-58. PubMed ID: 22911572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2.
    Saito T; Hirai R; Loo YM; Owen D; Johnson CL; Sinha SC; Akira S; Fujita T; Gale M
    Proc Natl Acad Sci U S A; 2007 Jan; 104(2):582-7. PubMed ID: 17190814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus reveals a novel early control in acute immune response.
    Arnaud N; Dabo S; Akazawa D; Fukasawa M; Shinkai-Ouchi F; Hugon J; Wakita T; Meurs EF
    PLoS Pathog; 2011 Oct; 7(10):e1002289. PubMed ID: 22022264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.
    Dansako H; Ikeda M; Kato N
    FEBS J; 2007 Aug; 274(16):4161-76. PubMed ID: 17651439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response.
    Tasaka M; Sakamoto N; Itakura Y; Nakagawa M; Itsui Y; Sekine-Osajima Y; Nishimura-Sakurai Y; Chen CH; Yoneyama M; Fujita T; Wakita T; Maekawa S; Enomoto N; Watanabe M
    J Gen Virol; 2007 Dec; 88(Pt 12):3323-3333. PubMed ID: 18024902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAP kinase p38α regulates type III interferon (IFN-λ1) gene expression in human monocyte-derived dendritic cells in response to RNA stimulation.
    Jiang M; Österlund P; Fagerlund R; Rios DN; Hoffmann A; Poranen MM; Bamford DH; Julkunen I
    J Leukoc Biol; 2015 Feb; 97(2):307-20. PubMed ID: 25473098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.
    Meylan E; Curran J; Hofmann K; Moradpour D; Binder M; Bartenschlager R; Tschopp J
    Nature; 2005 Oct; 437(7062):1167-72. PubMed ID: 16177806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.